Retrospective serosurveillance for anti-SARS-CoV-2 immunoglobulin during a time of low prevalence: A cautionary tale - 19/06/21

Summary |
We performed a retrospective screening of 428 serum samples for anti-SARS-CoV-2 immunoglobulin during a period of low prevalence. Employing two different serological tests yielded discrepant results for 10 samples; highlighting an increased risk of potential false positive results and the need for further confirmatory testing before publication of data.
Le texte complet de cet article est disponible en PDF.Keywords : Serological testing, SARS-CoV-2, Low prevalence
Plan
Vol 83 - N° 1
P. 119-145 - juillet 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.